MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

US unemployment has surged to its highest level in just under four years in the latest sign that Donald Trump’s erratic ...

Klarna see same growth ‘in 4 hours to Wise in 4 years’, UK inflation expected to stay at 3.8% - Stock market news and latest business and finance updates from Thursday ...

IRENA highlights unreliable electricity as a major barrier to healthcare in Mali and calls for tailored energy solutions for ...

Community Housing Aotearoa (CHA) is a peak body for the community housing sector. To achieve our vision of ‘all New ...

Employment and education goals - in reading, writing and mathematics - are classified as "at risk" of not being met, and two ...